S Squared Technology LLC Takes Position in DocGo Inc. $DCGO

S Squared Technology LLC acquired a new position in DocGo Inc. (NASDAQ:DCGO) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,055,271 shares of the company’s stock, valued at approximately $1,060,725,000. S Squared Technology LLC owned about 2.08% of DocGo as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of DCGO. Renaissance Technologies LLC raised its position in DocGo by 167.1% during the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after buying an additional 944,826 shares during the last quarter. Oxford Asset Management LLP increased its stake in shares of DocGo by 122.6% in the second quarter. Oxford Asset Management LLP now owns 93,126 shares of the company’s stock worth $146,000 after acquiring an additional 51,298 shares during the period. Empowered Funds LLC increased its stake in shares of DocGo by 14.6% in the fourth quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock worth $121,000 after acquiring an additional 17,607 shares during the period. BNP Paribas Financial Markets raised its holdings in shares of DocGo by 411.3% during the third quarter. BNP Paribas Financial Markets now owns 81,482 shares of the company’s stock worth $111,000 after purchasing an additional 65,545 shares during the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of DocGo by 44.3% during the fourth quarter. Wells Fargo & Company MN now owns 100,811 shares of the company’s stock worth $88,000 after purchasing an additional 30,957 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

Wall Street Analyst Weigh In

DCGO has been the topic of several recent research reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $3.00 price target on shares of DocGo in a report on Tuesday, August 18th. Canaccord Genuity Group reiterated a “hold” rating and set a $1.00 price objective on shares of DocGo in a research note on Tuesday, August 18th. Wall Street Zen raised DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $2.38.

DocGo Stock Performance

Shares of DCGO opened at $0.38 on Tuesday. DocGo Inc. has a one year low of $0.38 and a one year high of $1.73. The stock has a market capitalization of $37.68 million, a price-to-earnings ratio of -0.19 and a beta of 0.99. The stock has a 50 day moving average price of $0.58 and a 200 day moving average price of $0.63.

DocGo (NASDAQ:DCGO) last released its quarterly earnings data on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. The business had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. On average, analysts predict that DocGo Inc. will post -0.17 earnings per share for the current year.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.